DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-8.66%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$419M
AUM Growth
+$419M
(-4.7%)
Cap. Flow
+$1.35M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
47.79%
Holding
85
New
13
Increased
17
Reduced
18
Closed
2
Top Buys
| 1 |
AtriCure
ATRC
|
$8.38M |
| 2 |
UroGen Pharma
URGN
|
$7.87M |
| 3 |
Biohaven
BHVN
|
$3.47M |
| 4 |
Alkermes
ALKS
|
$2.91M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$2.17M |
Top Sells
| 1 |
Procept Biorobotics
PRCT
|
$2.5M |
| 2 |
Tandem Diabetes Care
TNDM
|
$2.18M |
| 3 |
Ascendis Pharma
ASND
|
$1.57M |
| 4 |
BioNTech
BNTX
|
$1.57M |
| 5 |
MediWound
MDWD
|
$998K |
Sector Composition
| 1 | Healthcare | 85.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.35M | 1.04% |
704,500
-5,000
| -0.7% | -$30.9K |
|
27
Century Therapeutics
IPSC
$40.4M
| $4.35M | 1.04% |
1,704,232
+396,825
| +30% | +$1.01M |
|
28
Alector
ALEC
$282M
| $4.14M | 0.99% |
912,928
| – | – |
|
|
TSVT
29
DELISTED
2seventy bio
TSVT
| $4.05M | 0.97% |
1,050,709
-153,342
| -13% | -$590K |
|
30
Arcus Biosciences
RCUS
$1.24B
| $3.86M | 0.92% |
253,217
+21,500
| +9% | +$327K |
|
31
Galapagos
GLPG
$2.06B
| $3.23M | 0.77% |
130,175
| – | – |
|
32
Insulet
PODD
$24.2B
| $3.21M | 0.77% |
15,900
| – | – |
|
33
Keros Therapeutics
KROS
$640M
| $3.1M | 0.74% |
67,754
| – | – |
|
|
SLRN
34
DELISTED
ACELYRIN
SLRN
| $3.06M | 0.73% |
693,609
+491,022
| +242% | +$2.17M |
|
|
35
Alkermes
ALKS
$4.95B
| $2.91M | 0.7% |
+120,700
| New | +$2.91M |
|
36
Stoke Therapeutics
STOK
$1.08B
| $2.8M | 0.67% |
207,427
+62,427
| +43% | +$843K |
|
37
Astria Therapeutics
ATXS
$394M
| $2.49M | 0.6% |
274,165
+50,900
| +23% | +$463K |
|
|
BCYC
38
Bicycle Therapeutics
BCYC
$492M
| $2.47M | 0.59% |
122,200
| – | – |
|
39
Perspective Therapeutics
CATX
$251M
| $2.31M | 0.55% |
231,634
-2,872,010
| -93% | -$785K |
|
40
Accuray
ARAY
$165M
| $2.22M | 0.53% |
1,222,358
| – | – |
|
|
ITOS
41
DELISTED
iTeos Therapeutics
ITOS
| $2.14M | 0.51% |
144,360
+45,800
| +46% | +$680K |
|
42
ARS Pharmaceuticals
SPRY
$1.08B
| $2.04M | 0.49% |
239,194
| – | – |
|
|
43
MediWound
MDWD
$180M
| $1.93M | 0.46% |
124,479
-64,274
| -34% | -$998K |
|
|
BWAY
44
Brainsway
BWAY
$296M
| $1.81M | 0.43% |
297,655
| – | – |
|
45
Inogen
INGN
$213M
| $1.7M | 0.41% |
208,790
| – | – |
|
46
Immatics
IMTX
$662M
| $1.68M | 0.4% |
145,000
| – | – |
|
|
RGLS
47
DELISTED
Regulus Therapeutics
RGLS
| $1.6M | 0.38% |
895,200
-175,348
| -16% | -$313K |
|
48
ProQR Therapeutics
PRQR
$256M
| $1.5M | 0.36% |
905,582
| – | – |
|
|
CMPS
49
Compass Pathways
CMPS
$452M
| $1.47M | 0.35% |
243,210
| – | – |
|
50
Allogene Therapeutics
ALLO
$249M
| $1.41M | 0.34% |
+605,100
| New | +$1.41M |
|